jq1 (MedChemExpress)
MedChemExpress is a verified supplier 
MedChemExpress manufactures this product 
94
Structured Review
MedChemExpress
jq1
Jq1, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 6 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/jq1/AZD5153/pm42457018-65-9-10
Average 94 stars, based on 6 article reviews
Jq1, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 6 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/jq1/AZD5153/pm42457018-65-9-10
Average 94 stars, based on 6 article reviews
jq1 - by Bioz Stars,
2026-09
94/100 stars
Images
Related Articles
Infection:Article Title: Selective Elimination of Myeloid HIV Reservoirs by Targeting Pro-survival Pathways. Article Snippet: .. Ten days after infection, Hu-HSC mice were given daily suppressive ART treatments with Jo ur na l P re -p ro of raltegravir (20 mg/kg b.w., Adooq Bioscience), BMS-663068 (20 mg/kg b.w., Adooq Bioscience) and Lamivudine (25 mg/kg b.w., Macleods Pharma.) orally for 40 days to establish latent infections as before.9 Then, the mice were treated by SECH, including IDB (2 mg/kg b.w., ENZO Life Sciences), ABT-263 (40 mg/kg b.w., MedChemExpress), SAR405 (40 mg/kg b.w., MedChemExpress) with Solvent:Article Title: Selective Elimination of Myeloid HIV Reservoirs by Targeting Pro-survival Pathways. Article Snippet: .. Ten days after infection, Hu-HSC mice were given daily suppressive ART treatments with Jo ur na l P re -p ro of raltegravir (20 mg/kg b.w., Adooq Bioscience), BMS-663068 (20 mg/kg b.w., Adooq Bioscience) and Lamivudine (25 mg/kg b.w., Macleods Pharma.) orally for 40 days to establish latent infections as before.9 Then, the mice were treated by SECH, including IDB (2 mg/kg b.w., ENZO Life Sciences), ABT-263 (40 mg/kg b.w., MedChemExpress), SAR405 (40 mg/kg b.w., MedChemExpress) with Mouse Assay:Article Title: 3D epigenomic remodelling mediated by Foxa1 drives gemcitabine resistance in pancreatic cancer. Article Snippet: 24 Jo urn al Pr e-p roo f Incubation:Article Title: Transcriptomic profiling of epigenetic regulators and metabolic reprogramming in human cholangiocarcinoma Article Snippet: .. After overnight incubation, cells were treated for 6 days with vehicle alone (0.1% DMSO), or the following inhibitors (MedChemExpress): |